483
Microvascular Tissue, IncFDA 483 - Microvascular Tissue, Inc - April 08, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Microvascular Tissue, Inc. in San Diego, CA, revealed significant deficiencies in their quality system for the biological product mVASC. Observations included inadequate complaint investigations, unvalidated manufacturing processes, and a lack of identity testing for drug product components. The firm also failed to thoroughly review batches that did not meet specifications.
Open in Dashboard
ID · f8d3d9c1-9f7f-4aad-8854-272921f824a7